BioSpace News Archive

Curago Health, a fast-growing patient engagement company, announced the creation of Curago Telehealth, a powerful new add-on to its platform delivering innovative patient registration, health record management and communications, as well as COVID-19 screenings.

As part of the U.S. Food and Drug Administration’s ongoing commitment to fight the Coronavirus Disease 2019 (COVID-19) pandemic, today the agency issued guidance for immediate implementation

Astellas Pharma US, (“Astellas”) and the Astellas Global Health Foundation are each expanding support for global and local communities fighting COVID-19 by providing up to $2 million of new financial assistance, in aggregate, to meet the urgent demand for resources to help patients, healthcare workers and first responders.

George Clinical, a global scientifically-backed clinical research organization, is leveraging the organization’s significant health and medical expertise, operational infrastructure and data science teams to actively advise stakeholders on potential COVID-19 vaccine and treatment studies.

Joerns Healthcare is doubling its healthcare bed and mattress production capacity to support customers and caregivers with critical care products necessary to meet COVID-19 patient needs.

Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced the promotion of John C. McKew, PhD to the position of Chief Operating Officer, effective April 1, 2020, in addition to his current role as Chief Scientific Officer

Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into a formal partnership with the U.S. government to expedite development of a plasma-derived therapy for patients with coronavirus disease 2019 (COVID-19).

EastWest Bioscience Inc. has released its second quarter results for the three months ending January 31, 2020..

While on quarantine, now is the perfect time for proven quit smoking online and phone support from the American Lung Association

Calviri, Inc., a biotech startup spun out of Arizona State University Biodesign Institute, focused on ending deaths from cancer, announced the closing of $2.25 million in seed round funding.